Posted Jan. 9, 2012 at 3:59 p.m.

Premium Lock Durham firm's gout treatment shows promise in clinical trial

Published: 2012-01-09 15:59:54
Updated: 2012-01-09 15:59:54

BioCryst BioCryst

BioCryst is studying the compound called BCX4208 as an adjunct therapy for patients using the gout drug allopurinol. Allopurinol reduces the uric acid production that leads to inflammation and joint pain experienced by gout patients....

Read More
Read More

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll